Authors
Latest:
Dr Sampalis: What I wish I knew before entering optometryMaria Sampalis, OD, shares what she wishes she knew before entering the field.
Latest:
Rapid progress: An update on corneal endothelial cell therapyEarlier this year, Aurion’s cell therapy received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency for the management of bullous keratopathy, marking the first regulatory approval in the world for an allogeneic cell therapy to manage corneal endothelial disease.
Latest:
How to treat patients with delusional parasitosisDelusional parasitosis or Ekbom’s syndrome is a patient’s mistaken belief that he is infested by parasites such as mites, lice, fleas, spiders, worms, bacteria, or other organisms. Scott Schachter, OD, discusses the challenges ODs face when working with these patients.
Latest:
How to manage adenoviral conjunctivitisAdenoviral conjunctivitis (Ad-CS) has never been so popular a topic as it is right now. With over 26 million viewers tuning in to watch the Olympics, Americans have watched Bob Costas’s unilateral conjunctivitis worsen, then become bilateral. His ocular condition prompted many commentators to remark, “Can’t someone help him?”
Latest:
How to manage adenoviral conjunctivitisAdenoviral conjunctivitis (Ad-CS) has never been so popular a topic as it is right now. With over 26 million viewers tuning in to watch the Olympics, Americans have watched Bob Costas’s unilateral conjunctivitis worsen, then become bilateral. His ocular condition prompted many commentators to remark, “Can’t someone help him?”
Latest:
AAOpt 2022: Understanding antibiotics: the how and when to prescribeBlair Lonsberry, MS, OD, MEd, FAAO, shares highlights from his 2022 American Academy of Optometry presentation, "Simplifying systemic antibiotics."
Latest:
Targeting dry eye in glaucoma patientsA poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
Latest:
Back to the basics: The importance of treating inflammation AND obstruction for dry eyeDerek Cunningham, OD, FAAO, gives key takeaways from his AAOpt 2022 discussion, "Back to the basics: The importance of treating inflammation AND obstruction for dry eye."
Latest:
AAOpt 2023: A renaissance of new glaucoma treatment optionsAs new treatment options continue to enter the glaucoma space, clinicians can provide the best care to each individual patient.
